Kidney function and psoriasis drug: a safety check
NCT ID NCT06380153
First seen Dec 29, 2025 · Last updated May 07, 2026 · Updated 19 times
Summary
This study tested how the psoriasis drug Hemay005 behaves in people with mild or moderate kidney issues versus those with normal kidneys. 26 adults took a single dose, and researchers measured drug levels in the blood. The goal was to help doctors decide the right dose for patients with kidney problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital of Tongji Medical College; Huazhong University of Science and Technology
Wuhan, Hubei, China
Conditions
Explore the condition pages connected to this study.